Translating Adult Exposure Targets Into Pediatric Regimens

Why Translate Exposure Rather Than Milligrams?

An adult dose is not itself a pharmacokinetic target. The same number of milligrams can produce different exposures in adults and children because clearance, bioavailability, and other pharmacokinetic properties may differ. A more defensible translation begins with an adult exposure that is considered appropriate for the treatment objective, then asks what pediatric regimen is predicted to produce that exposure.

This is a model-based calculation, not a claim that matching one exposure measure guarantees the same clinical outcome. The exposure target must be appropriate for the drug and indication, and the pediatric model must be suitable for the child and the intended regimen. The earlier material on combined allometric and maturation scaling provides one way to predict pediatric clearance; here, the predicted clearance is used to translate an exposure target into a dose.

Definition: For a drug with linear pharmacokinetics, let \(D\) be the amount given at each dose, \(\tau\) the dosing interval in hours, \(F\) the fraction of the dose reaching systemic circulation, and \(CL\) the systemic clearance in L/h. At steady state, the area under the concentration-time curve over one dosing interval is \(AUC_{\tau}=FD/CL\). The long-run 24-hour average exposure, expressed as \(AUC_{24}\), is \(24FD/(\tau CL)\). For the same target \(AUC_{24}\), the corresponding total daily dose is \(AUC_{24}CL/F\).

Assumptions Behind the Translation

The equations above are useful only when their assumptions are reasonable. They assume linear, time-invariant pharmacokinetics over the dose range and time period of interest: exposure is proportional to dose, and clearance and bioavailability do not change as the dose changes. The repeated regimen is assumed to be stable and at steady state for interval-based interpretation. The dose and interval are known, and the stated \(F\) and \(CL\) correspond to the route, formulation, and patient population being considered.

For an intravenous dose, \(F=1\). For an oral or other extravascular dose, \(F\) may be less than one and may be uncertain. If clearance or bioavailability varies substantially with age, disease, concomitant treatment, or dose, a single fixed value may not adequately predict exposure. In that situation, the simple calculation should not be treated as a reliable dose recommendation.

The adult reference exposure can come from a measured adult regimen or from an adult model and regimen judged to provide an appropriate treatment target. If it is calculated from an adult dose, the adult \(F\), \(CL\), and \(\tau\) must all refer to that regimen. The pediatric calculation then uses pediatric—not adult—pharmacokinetic quantities. No assumption that milligrams scale directly with body weight is needed.

Deriving the Exposure-Based Dose

The steady-state interval relationship follows from mass balance. During a complete dosing interval at steady state, the amount of drug in the body at the end of the interval equals the amount at the beginning. Thus, the amount eliminated during the interval equals the systemically available amount of the dose, \(FD\). Under linear clearance, the elimination rate is \(CL\,C(t)\), where \(C(t)\) is concentration. Integrating that rate over the interval gives:

FD=\int_0^\tau CL\,C(t)\,dt =CL\int_0^\tau C(t)\,dt =CL\,AUC_\tau.

Rearranging yields \(AUC_\tau=FD/CL\). A regimen gives \(24/\tau\) doses per day on average, so the long-run daily exposure is:

AUC_{24}=\frac{24}{\tau}AUC_\tau =\frac{24FD}{\tau CL}.

Solving for dose amount per administration gives \(D=AUC_{24}\tau CL/(24F)\). Equivalently, the total daily dose is:

D_{\text{daily}}=\frac{AUC_{24}CL}{F}, \qquad D_{\text{per dose}}=\frac{AUC_{24}CL\tau}{24F}.

The units provide a useful check. If \(AUC_{24}\) is in mg·h/L and \(CL\) is in L/h, their product is mg per 24-hour day. Dividing by \(F\), a dimensionless fraction, retains those dose units. To obtain an amount per administration, multiply the daily amount by \(\tau/24\).

Worked Example: Translate an Adult Reference AUC Into a Child’s Daily Dose

Hypothetical data. An adult reference regimen is 500 mg orally every 12 hours. Assume adult \(F=0.80\) and \(CL=5.00\) L/h. A pediatric model predicts that a particular child has \(CL=1.40\) L/h and \(F=0.80\) for the intended oral formulation. Calculate the child’s dose to match the adult regimen’s long-run \(AUC_{24}\), initially keeping a 12-hour interval.

First calculate the adult reference exposure. The regimen has \(D=500\) mg and \(\tau=12\) h:

AUC_{24,\text{adult}} =\frac{24(0.80)(500\ \text{mg})} {(12\ \text{h})(5.00\ \text{L/h})} =\frac{9600}{60} =160\ \text{mg}\cdot\text{h/L}.

Now use the child’s predicted clearance and bioavailability. The required total daily dose is:

D_{\text{daily,child}} =\frac{(160\ \text{mg}\cdot\text{h/L})(1.40\ \text{L/h})}{0.80} =280\ \text{mg/day}.

For a 12-hour interval, there are two administrations per day, so the amount per administration is \(280/2=140\) mg. The calculation predicts the same \(AUC_{24}\) as the adult reference under the stated assumptions; it does not imply that 140 mg is clinically suitable for every child. The adult total daily amount is 1000 mg, but the child’s calculated amount was obtained from the exposure target and pediatric parameters, not by direct milligram or weight scaling.

Using a Pediatric Clearance Model

The exposure equation does not dictate how pediatric clearance is estimated. It takes the model’s predicted \(CL\) as an input. For example, an established model might express clearance as a typical adult value multiplied by a body-size function and an age-related maturation function. The particular model, covariates, and parameter estimates must be appropriate for the child; a formula should not be assembled from convenient values without justification.

The following calculation illustrates the arithmetic when a model has already been specified. It is not a universal clearance model. The assumptions are that the model applies to this hypothetical child, the clearance prediction is in L/h, and the predicted bioavailability is appropriate for the proposed route.

Worked Example: Calculate a Dose From Allometric and Maturation Terms

Hypothetical model and data. Suppose a validated model for this example predicts clearance as \(CL=CL_{\text{typ}}(WT/70)^{0.75}M\), where \(CL_{\text{typ}}=6.00\) L/h, body weight \(WT=20.0\) kg, and the model’s maturation multiplier for this child is \(M=0.85\). The model predicts oral \(F=0.90\). Use the adult target \(AUC_{24}=160\) mg·h/L and calculate a regimen every 8 hours.

First calculate the body-size term and predicted clearance:

\left(\frac{20.0\ \text{kg}}{70\ \text{kg}}\right)^{0.75} =(0.2857)^{0.75} \approx 0.391, \qquad CL=6.00(0.391)(0.85) \approx 1.99\ \text{L/h}.

Then calculate the total daily dose needed for the target exposure:

D_{\text{daily}} =\frac{(160\ \text{mg}\cdot\text{h/L})(1.99\ \text{L/h})}{0.90} \approx 354\ \text{mg/day}.

An 8-hour interval corresponds to three doses per day. Therefore:

D_{\text{per dose}}=\frac{354\ \text{mg/day}}{3} \approx 118\ \text{mg every 8 hours}.

The calculation uses the model-predicted clearance and bioavailability to translate exposure into amount. The weight term contributes to the clearance prediction; it does not mean the adult dose should be multiplied by the child’s weight divided by the adult’s weight. The result is conditional on the model’s validity and on linear, stable pharmacokinetics.

Intervals That Do Not Divide 24 Hours

A common arithmetic error occurs when \(\tau\) does not divide 24. For example, a 10-hour interval contains two complete intervals in 20 hours, but those intervals do not cover the entire 24-hour day. Summing only two complete interval AUCs omits exposure associated with the remaining 4 hours. The long-run average \(AUC_{24}\) for a stable linear regimen is still calculated from \(24FD/(\tau CL)\), which accounts for the dosing rate across time.

The formula gives the daily average exposure for the repeated regimen. It should not be confused with the integral over every particular 24-hour window at an arbitrarily chosen phase of a non-24-hour schedule. If the question is the actual AUC in a specific window, integrate the predicted concentration curve over that full window. A partial-interval AUC generally cannot be obtained by taking the same fraction of a full-interval AUC; concentration need not be constant within the interval.

Worked Example: Avoid Omitting Exposure With a 10-Hour Interval

Hypothetical data. A linear, stable regimen gives 100 mg every 10 hours, with \(F=0.80\) and \(CL=2.00\) L/h. Calculate its long-run average \(AUC_{24}\). Then identify the error in summing only the complete 10-hour intervals within 24 hours.

The full-interval exposure is \(AUC_{10}=FD/CL\):

AUC_{10} =\frac{(0.80)(100\ \text{mg})}{2.00\ \text{L/h}} =40.0\ \text{mg}\cdot\text{h/L}.

The daily average exposure follows directly from the regimen’s dosing rate:

AUC_{24} =\frac{24(0.80)(100\ \text{mg})} {(10\ \text{h})(2.00\ \text{L/h})} =96.0\ \text{mg}\cdot\text{h/L}.

Adding only two complete interval AUCs gives \(2(40.0)=80.0\) mg·h/L, but those intervals cover only 20 hours. That sum is not the 24-hour exposure. The remaining 4 hours must be represented when calculating a particular 24-hour-window AUC from a concentration profile. For the long-run daily average used in this dose translation, the formula above accounts for the full dosing rate and gives 96.0 mg·h/L; it does not assert that the partial interval contributes \(4/10\) of one interval’s AUC.

What Exposure Matching Does—and Does Not—Match

Matching \(AUC_{24}\) matches an aggregate measure of systemic exposure under the stated assumptions. It does not necessarily match \(C_{\max}\), \(C_{\min}\), time above a concentration threshold, or the shape of the concentration-time curve. Those quantities depend on the interval, absorption, distribution, and elimination as well as the total daily dose. If the treatment objective is driven by a peak, trough, or time-above-threshold measure, a dose calculation based only on AUC is not sufficient; the relevant profile must be evaluated with an appropriate pharmacokinetic model.

A different interval can preserve the same average exposure while changing the amount per dose and the within-interval fluctuation. For a fixed \(AUC_{24}\), the formula \(D_{\text{per dose}}=AUC_{24}CL\tau/(24F)\) shows that a longer interval requires a larger amount per administration under the linear model. Whether that schedule is appropriate is a separate pharmacologic question, not answered by this equation alone.

Exposure matching also does not remove model uncertainty or guarantee equal response across age groups. The adult target may not be appropriate for a child, and the pediatric prediction may be less reliable in children whose characteristics lie outside the model’s development data. The calculation is best viewed as a transparent quantitative bridge between an exposure objective and a model-predicted regimen, with clinical and model checks still required.

Diagnostics and Common Pitfalls

Before using a calculated amount, check that the dose, interval, \(F\), and \(CL\) refer to compatible routes and units. Verify that the predicted clearance is positive and plausible for the child and that the model supports the child’s age and body size. Confirm that the assumed exposure target is defined over the same time basis as the calculation. A target \(AUC_\tau\) is not interchangeable with \(AUC_{24}\) unless the interval conversion is made correctly.

A calculation can also be internally correct yet answer the wrong clinical question. If peak or trough concentrations are the intended target, assess those concentrations rather than inferring them from AUC alone. If the drug has nonlinear kinetics, changing the dose may change clearance or bioavailability; then proportional dose-to-AUC scaling is not valid. A steady-state equation should not be applied as though the patient were already at steady state when concentrations are still accumulating or the regimen has recently changed.

Wrong: “The child weighs one-fifth as much as the adult, so give one-fifth of the adult dose.” Correction: Use the pediatric model’s clearance and bioavailability to calculate the amount for the target exposure.
Wrong: “Two 10-hour interval AUCs equal the 24-hour AUC.” Correction: Those intervals cover only 20 hours; use the full 24-hour average formula or integrate the full specified window.
Wrong: “Matching AUC guarantees the same peak and trough.” Correction: AUC is an integrated exposure measure; peak and trough also depend on the concentration-time profile and schedule.
Wrong: “A model-based result is precise because it has several decimal places.” Correction: Report sensible precision and recognize that the prediction depends on model applicability and input assumptions.

Key takeaway: To translate an adult reference exposure into a pediatric amount, establish the target exposure, predict the child’s relevant \(CL\) and \(F\), and calculate \(D_{\text{daily}}=AUC_{24}CL/F\). Then assess whether the proposed interval and the exposure measure match the clinical objective.

Check Your Understanding

Try each question, then compare your reasoning with the solutions.

A child has predicted \(CL=1.20\) L/h and \(F=0.80\). What total daily dose corresponds to a target \(AUC_{24}=100\) mg·h/L?
For the dose in question 1, what amount per administration gives a 12-hour interval?
Why can a child’s dose not generally be obtained by multiplying the adult milligram dose by the ratio of their body weights?
A regimen is given every 10 hours. Why is summing two complete interval AUCs not a 24-hour AUC?
What additional concern arises if the desired treatment target is a trough concentration rather than \(AUC_{24}\)?

Solutions. (1) \(D_{\text{daily}}=100(1.20)/0.80=150\) mg/day. (2) A 12-hour interval gives two administrations per day, so \(150/2=75.0\) mg per administration. (3) Body weight alone does not specify clearance or bioavailability; a pediatric pharmacokinetic model supplies the relevant prediction, and the dose is calculated from the exposure target. (4) Two 10-hour intervals cover only 20 hours, leaving 4 hours unrepresented; use the long-run \(AUC_{24}=24FD/(\tau CL)\) or integrate the concentration curve over the specified 24-hour window. (5) Matching AUC does not ensure a matching trough. The concentration-time profile and dosing interval must be evaluated against the trough objective.